When plasma cells exceed 10% in the bone marrow and M-protein reaches 30 g/L in the blood, the condition is classified as smoldering MM (sMM) [14], with a 22% chance of progression to MM within two years and a median progression time of 6.4 years [15]. The gene discussed is MYOM2; the disease is Miyoshi myopathy.